Ectopic Pregnancy — Diagnosis & Management

Key Points

• A positive pregnancy test plus no visible intrauterine pregnancy defines pregnancy of unknown location, not a confirmed ectopic.
• Hemodynamic instability or suspected rupture requires immediate surgical management, not further serial hCG testing.
• Do not use one hCG value or a rigid discriminatory zone to terminate a potentially viable desired pregnancy.
• Serial hCG, repeat transvaginal ultrasound, and clinical symptoms must be interpreted together.
• Methotrexate is only for selected stable patients who can comply with follow-up and have no contraindication.
• Ectopic rupture can occur despite a low or falling hCG, so symptoms always matter.
• Assisted reproduction increases the possibility of heterotopic pregnancy even when an intrauterine pregnancy is seen.
• After methotrexate, hCG follow-up must continue until resolution is documented.

Algorithm

1. Assess airway, circulation, pain, syncope, and peritoneal signs; establish IV access and resuscitate if unstable.
2. Confirm pregnancy and obtain quantitative hCG, CBC, type and screen, and transvaginal ultrasound.
3. If rupture or major hemorrhage is suspected, activate urgent gynecologic surgery.
4. If stable with a definite intrauterine pregnancy, evaluate other causes of symptoms while remembering heterotopic pregnancy in high-risk contexts.
5. If pregnancy location is unknown, arrange serial hCG and repeat ultrasound based on symptoms and initial findings.
6. For confirmed or highly likely unruptured ectopic, compare methotrexate, surgery, and selected expectant management.
7. If methotrexate is used, monitor hCG response exactly according to the chosen regimen and reassess urgently for worsening pain or instability.
8. Provide Rh prophylaxis when indicated and arrange follow-up through complete resolution.

Clinical Synopsis & Reasoning

Presentation ranges from mild unilateral pelvic discomfort or spotting to shoulder pain, peritoneal signs, syncope, and hemorrhagic shock. Ask about last menstrual period, pregnancy desirability, prior ectopic pregnancy, tubal surgery, pelvic inflammatory disease, infertility treatment, and intrauterine-device use. A prior ectopic substantially raises risk, but many affected patients have no recognized risk factor. Perform pregnancy testing early in patients with compatible symptoms. Transvaginal ultrasound should evaluate for a definite intrauterine gestational sac with yolk sac or embryo, adnexal mass, and free fluid. An empty uterus with a positive test is classified as pregnancy of unknown location until follow-up establishes location or resolution. A single hCG value cannot reliably determine location or viability, and rigid use of a low discriminatory threshold can interrupt a potentially viable intrauterine pregnancy. Serial hCG change over approximately 48 hours, symptoms, and repeat ultrasound are interpreted together. Hemoglobin can be initially normal in acute hemorrhage, so hemodynamic assessment is more important than one CBC value. Heterotopic pregnancy is rare after spontaneous conception but more common with assisted reproduction and should be considered even when an intrauterine pregnancy is visualized if symptoms are concerning.

Treatment Strategy & Disposition

Hemodynamic instability, peritoneal signs, significant hemoperitoneum with concerning physiology, or suspected rupture requires immediate obstetric/gynecologic surgery and resuscitation. Stable patients with a confirmed or highly likely unruptured tubal ectopic may be managed surgically or with methotrexate depending on hCG pattern, ectopic size and cardiac activity, symptoms, ability to return for serial testing, and contraindications. Methotrexate is inappropriate in unstable patients, rupture, inability to ensure follow-up, significant hepatic, renal, hematologic, pulmonary, or immunologic contraindications, and several other situations. A single-dose protocol is common for selected lower-risk patients, but hCG must be measured on protocol days and then followed to undetectable because treatment failure and rupture remain possible. Expectant management is reserved for carefully selected asymptomatic stable patients with low and falling hCG who can adhere to close follow-up. Rh(D)-negative patients with bleeding or surgical management should receive Rh immune globulin according to current obstetric guidance and gestational context. Pain control and shared decision-making should address fertility priorities and the relative advantages of salpingostomy versus salpingectomy when surgery is required.

Epidemiology / Risk Factors

• Ectopic pregnancy occurs in roughly 1 to 2 percent of recognized pregnancies, with variation by population and ascertainment.
• Tubal implantation is the dominant form, but cervical, interstitial, cesarean-scar, ovarian, and abdominal locations occur.
• Previous ectopic pregnancy, tubal surgery, prior pelvic infection, infertility, and assisted reproductive technology increase risk.
• An intrauterine device greatly reduces pregnancy overall, but a pregnancy that occurs with an IUD in place has a higher relative probability of being ectopic.
• Ectopic pregnancy remains an important cause of pregnancy-related hemorrhage and preventable maternal morbidity.

Investigations

Methotrexate Selection (Abbrev.)

Pharmacology

Prognosis / Complications

• Early diagnosis before rupture allows effective medical or minimally invasive surgical management in most patients.
• Ruptured ectopic pregnancy can cause massive hemorrhage and death without rapid operative control.
• Methotrexate success is highest in carefully selected patients with lower hCG levels, no fetal cardiac activity, and reliable follow-up.
• A previous ectopic increases the risk of another ectopic pregnancy, so early ultrasound is appropriate in a future pregnancy.
• Emotional impact can be substantial because treatment also represents pregnancy loss and may affect fertility plans.

Patient Education / Counseling

• Explain clearly whether the pregnancy location is known, unknown, or confirmed ectopic and what uncertainty remains.
• For pregnancy of unknown location, provide exact timing for repeat hCG or ultrasound and emergency return instructions.
• After methotrexate, avoid pregnancy until the recommended interval has passed and follow medication, alcohol, folate, and sun-exposure precautions given by the treating team.
• Seek emergency care for worsening abdominal pain, shoulder pain, fainting, heavy bleeding, weakness, or shortness of breath.
• Acknowledge pregnancy loss and offer reproductive, fertility, and emotional-support resources as appropriate.

Notes

The most important distinction in early-pregnancy pain or bleeding is not simply intrauterine versus ectopic. It is stable versus unstable, followed by definite location versus pregnancy of unknown location. Stable uncertainty can be managed deliberately with serial hCG and ultrasound, but instability demands immediate hemorrhage control. Methotrexate is highly effective when used for the right patient, yet it requires strict follow-up because rupture remains possible until the ectopic pregnancy has completely resolved.

References

1. ACOG Practice Bulletin 193: Tubal Ectopic Pregnancy, reaffirmed 2025 — Link